BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2182437)

  • 1. More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.
    Sallan SE; Gelber RD; Kimball V; Donnelly M; Cohen HJ
    Haematol Blood Transfus; 1990; 33():459-66. PubMed ID: 2182437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987.
    Zintl F; Malke H; Reimann M; Dörffel W; Domula M; Eggers G; Exadaktylos P; Kotte W; Krause I; Kunert W
    Haematol Blood Transfus; 1990; 33():478-82. PubMed ID: 2182440
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
    CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85.
    Schaison G; Olive D; Leverger G; Vannier JP; de Lumley L; Bancillon A; Cornu G
    Haematol Blood Transfus; 1990; 33():467-72. PubMed ID: 2182438
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
    Fengler R; Hartmann R; Bode U; Janka G; Jürgens H; Riehm H; Henze G
    Haematol Blood Transfus; 1990; 33():511-5. PubMed ID: 2182445
    [No Abstract]   [Full Text] [Related]  

  • 7. BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.
    Henze G; Fengler R; Hartmann R; Niethammer D; Schellong G; Riehm H
    Haematol Blood Transfus; 1990; 33():619-26. PubMed ID: 2182452
    [No Abstract]   [Full Text] [Related]  

  • 8. [Israel national childhood acute lymphoblastic leukemia study].
    Stark B; Abramov A; Attias D; Balin A; Burstein Y; Barak Y; Jaber L; Goshen Y; Dvir A; Hagai E
    Harefuah; 1990 Apr; 118(7):373-82. PubMed ID: 2351344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    Cherlow JM; Steinherz PG; Sather HN; Gaynon PS; Grossman NJ; Kersey JH; Johnstone HS; Breneman JC; Trigg ME; Hammond GD
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1001-9. PubMed ID: 8262820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.
    Schorin MA; Blattner S; Gelber RD; Tarbell NJ; Donnelly M; Dalton V; Cohen HJ; Sallan SE
    J Clin Oncol; 1994 Apr; 12(4):740-7. PubMed ID: 8151317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988).
    Veerman AJ; Hählen K; Kamps WA; Vanleeuwen EF; de Vaan GA; Vanwering ER; Vanderdoes-Vandenberg A; Solbu G; Suciu S
    Haematol Blood Transfus; 1990; 33():473-7. PubMed ID: 2182439
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).
    Silverman LB; Stevenson KE; O'Brien JE; Asselin BL; Barr RD; Clavell L; Cole PD; Kelly KM; Laverdiere C; Michon B; Schorin MA; Schwartz CL; O'Holleran EW; Neuberg DS; Cohen HJ; Sallan SE
    Leukemia; 2010 Feb; 24(2):320-34. PubMed ID: 20016537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results and significance of six randomized trials in four consecutive ALL-BFM studies.
    Riehm H; Gadner H; Henze G; Kornhuber B; Lampert F; Niethammer D; Reiter A; Schellong G
    Haematol Blood Transfus; 1990; 33():439-50. PubMed ID: 2182435
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of childhood acute lymphoblastic leukemia: randomized trials of protocols CCLSG-L 841 and I 841. (Phase III study). Children's Cancer and Leukemia Study Group].
    Rinsho Ketsueki; 1989 Jul; 30(7):967-74. PubMed ID: 2681882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.
    Bührer C; Henze G; Hofmann J; Reiter A; Schellong G; Riehm H
    Haematol Blood Transfus; 1990; 33():500-3. PubMed ID: 2182444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by the Children's Cancer and Leukemia Study Group.
    Koizumi S; Fujimoto T
    Int J Hematol; 1994 Feb; 59(2):99-112. PubMed ID: 8018909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.
    Moghrabi A; Levy DE; Asselin B; Barr R; Clavell L; Hurwitz C; Samson Y; Schorin M; Dalton VK; Lipshultz SE; Neuberg DS; Gelber RD; Cohen HJ; Sallan SE; Silverman LB
    Blood; 2007 Feb; 109(3):896-904. PubMed ID: 17003366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
    J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.